Bethesda System (TBS) 2nd mbbs pathology ROBBINS AND COTRANS PATHOGENESIS OF DISEAS 2ND YEAR
Explain the Cervical Bethesda System with Pap smear categories
"cervical cancer screening" AND Bethesda
NCI Bethesda System cervical cytology Pap test categories ASC-US LSIL HSIL
Pap smear cervical cytology LSIL HSIL koilocytes Bethesda System diagram
NILM does not mean the cervix is necessarily free from all disease. It means the smear does not show an intraepithelial lesion or malignancy.

| Bethesda cytology term | Approximate histological correlation | Significance |
|---|---|---|
| ASC-US | Equivocal, may be reactive or HPV-related | Minor abnormality |
| ASC-H | Possible HSIL | HSIL must be excluded |
| LSIL | HPV effect and CIN 1 | Usually low-risk lesion; many regress |
| HSIL | CIN 2 and CIN 3 | Significant precancerous lesion |
| Squamous cell carcinoma | Invasive squamous carcinoma | Malignant |
| AGC | Possible cervical/endometrial glandular lesion | Requires evaluation |
| AIS | Preinvasive endocervical adenocarcinoma | Glandular precursor lesion |
| Adenocarcinoma | Invasive glandular malignancy | Malignant |
| Old histopathology terminology | Bethesda cytology terminology |
|---|---|
| Mild dysplasia | LSIL |
| CIN 1 | LSIL |
| Moderate dysplasia, CIN 2 | HSIL |
| Severe dysplasia, CIN 3 | HSIL |
| Carcinoma in situ | HSIL |
Create a one-page Bethesda classification table
"cervical cytology" AND Bethesda
Bethesda System 2014 cervical cytology categories NILM ASC-US ASC-H LSIL HSIL AGC AIS
| Report category | Abbreviation / full form | Cytological meaning | Histological correlation / significance |
|---|---|---|---|
| Specimen unsatisfactory | - | Inadequate cells or smear obscured by blood, inflammation, poor fixation, etc. | Repeat sample is required. |
| Negative for intraepithelial lesion or malignancy | NILM | No precancer or malignancy detected. Reactive changes, inflammation, atrophy, or organisms may be noted. | Normal/benign cytology. |
| Atypical squamous cells of undetermined significance | ASC-US | Squamous atypia greater than reactive change, but insufficient for LSIL. | Equivocal finding; may be reactive, HPV-related, or early LSIL. |
| Atypical squamous cells, cannot exclude HSIL | ASC-H | Abnormal squamous cells suspicious for HSIL, but diagnostic criteria are incomplete. | Must exclude underlying high-grade lesion. |
| Low-grade squamous intraepithelial lesion | LSIL | HPV cytopathic effect, often with koilocytosis; mild nuclear atypia. | HPV infection + CIN 1 (mild dysplasia). Many regress spontaneously. |
| High-grade squamous intraepithelial lesion | HSIL | Marked atypia: high nuclear-cytoplasmic ratio, hyperchromasia, coarse chromatin, and irregular nuclear outline. | CIN 2 and CIN 3, including severe dysplasia/carcinoma in situ. True precancerous lesion. |
| Squamous cell carcinoma | SCC | Malignant squamous cells in smear. | Suggests invasive cervical squamous carcinoma. Confirm by biopsy. |
| Atypical glandular cells | AGC | Abnormal glandular cells, beyond reactive changes. May be specified as endocervical or endometrial. | May indicate significant endocervical or endometrial pathology. |
| Atypical glandular cells, favour neoplastic | AGC, favour neoplastic | Glandular atypia more suspicious for neoplasia than AGC-NOS. | Possible AIS or invasive adenocarcinoma. |
| Endocervical adenocarcinoma in situ | AIS | Neoplastic glandular cells without evidence of stromal invasion on cytology. | Preinvasive endocervical glandular neoplasia. |
| Adenocarcinoma | - | Malignant glandular cells, possibly endocervical, endometrial, or extrauterine. | Invasive glandular malignancy. |
| Older terminology / CIN | Bethesda terminology |
|---|---|
| HPV changes / koilocytosis | LSIL |
| Mild dysplasia / CIN 1 | LSIL |
| Moderate dysplasia / CIN 2 | HSIL |
| Severe dysplasia / CIN 3 | HSIL |
| Carcinoma in situ | HSIL |
Explain in brief for 5marks
"cervical cytology" AND Bethesda
Bethesda System cervical cytology Pap smear categories ASC-US ASC-H LSIL HSIL AGC
| Category | Meaning / correlation |
|---|---|
| NILM | Negative for intraepithelial lesion or malignancy. May show inflammation, infection, or atrophy. |
| ASC-US | Atypical squamous cells of undetermined significance. Changes are more than reactive but insufficient for LSIL. |
| ASC-H | Atypical squamous cells, cannot exclude HSIL. |
| LSIL | Low-grade squamous intraepithelial lesion. Includes HPV changes/koilocytosis and CIN 1 (mild dysplasia). |
| HSIL | High-grade squamous intraepithelial lesion. Includes CIN 2 and CIN 3, including severe dysplasia/carcinoma in situ. It is a significant precancerous lesion. |
| SCC | Squamous cell carcinoma. Suggests invasive cancer. |
| AGC | Atypical glandular cells. May arise from endocervix or endometrium. |
| AIS / Adenocarcinoma | Adenocarcinoma in situ or invasive adenocarcinoma. |